Ryan Zimmerman
Stock Analyst at BTIG
(3.81)
# 649
Out of 5,129 analysts
237
Total ratings
49.5%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $94.47 | +18.56% | 11 | Feb 10, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.52 | +97.36% | 3 | Feb 10, 2026 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $0.96 | +522.92% | 7 | Feb 9, 2026 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $91 | $78.72 | +15.60% | 6 | Feb 9, 2026 | |
| SYK Stryker | Maintains: Buy | $410 → $412 | $362.61 | +13.62% | 19 | Jan 30, 2026 | |
| GKOS Glaukos | Maintains: Buy | $123 → $131 | $109.30 | +19.86% | 16 | Jan 28, 2026 | |
| ISRG Intuitive Surgical | Reiterates: Buy | $616 | $494.86 | +24.48% | 23 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Neutral | $349 | $339.69 | +2.74% | 21 | Jan 16, 2026 | |
| ENOV Enovis | Initiates: Buy | $41 | $22.27 | +84.10% | 1 | Jan 6, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $9 | $3.72 | +141.94% | 10 | Dec 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $11.24 | +113.52% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $1.91 | - | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $80.57 | +24.12% | 2 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $91 | $78.64 | +15.72% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $3.83 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.59 | +152.48% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.00 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $27.36 | +2.34% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $16.95 | +35.69% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.13 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $149.54 | +30.40% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.48 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $28.29 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $12.40 | +85.46% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $112.83 | +31.17% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.03 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $87.84 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $11.03 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.43 | +204.07% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.37 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $134.32 | +48.90% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $252.93 | +38.38% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $100.05 | +27.94% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.48 | +20.24% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.04 | +146.48% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.22 | +905.75% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.64 | - | 3 | Apr 2, 2020 |
Zimmer Biomet Holdings
Feb 10, 2026
Reiterates: Buy
Price Target: $112
Current: $94.47
Upside: +18.56%
Spectral AI
Feb 10, 2026
Reiterates: Buy
Price Target: $3
Current: $1.52
Upside: +97.36%
Humacyte
Feb 9, 2026
Reiterates: Buy
Price Target: $6
Current: $0.96
Upside: +522.92%
GE HealthCare Technologies
Feb 9, 2026
Reiterates: Buy
Price Target: $91
Current: $78.72
Upside: +15.60%
Stryker
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $362.61
Upside: +13.62%
Glaukos
Jan 28, 2026
Maintains: Buy
Price Target: $123 → $131
Current: $109.30
Upside: +19.86%
Intuitive Surgical
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $494.86
Upside: +24.48%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $339.69
Upside: +2.74%
Enovis
Jan 6, 2026
Initiates: Buy
Price Target: $41
Current: $22.27
Upside: +84.10%
Organogenesis Holdings
Dec 26, 2025
Reiterates: Buy
Price Target: $9
Current: $3.72
Upside: +141.94%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $11.24
Upside: +113.52%
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $1.91
Upside: -
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $80.57
Upside: +24.12%
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $78.64
Upside: +15.72%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.83
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.59
Upside: +152.48%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.00
Upside: -
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $27.36
Upside: +2.34%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $16.95
Upside: +35.69%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.13
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $149.54
Upside: +30.40%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $34.48
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $28.29
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $12.40
Upside: +85.46%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $112.83
Upside: +31.17%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.03
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $87.84
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $11.03
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.43
Upside: +204.07%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.37
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $134.32
Upside: +48.90%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $252.93
Upside: +38.38%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $100.05
Upside: +27.94%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.48
Upside: +20.24%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.04
Upside: +146.48%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.22
Upside: +905.75%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $33.64
Upside: -